Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)

NCT04046887 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Unable to proceed due to Neulasta difficulties and other complications.

Conditions

Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Lonsurf
DRUG: Gemcitabine
DRUG: Nab-Paclitaxel

Sponsor

Patrick Joseph Loehrer Sr.

Collaborators

[object Object]
[object Object]